Evaluation of tumour infiltrating immune cells into the orthotopic and metastatic tumour microenvironment using bioluminescent syngeneic cell line models in immune competent mice following treatment with checkpoint inhibitors

被引:0
|
作者
Andrew, M. [1 ]
Nektaria, P. [1 ]
Simon, J. [1 ]
Jane, W. [2 ]
Jason, K. [2 ]
Vicky, L. [2 ]
Kelly, J. [2 ]
Russell, G. [3 ]
Neil, W. [4 ]
Kumari, R. [5 ]
机构
[1] Crown Biosci UK Ltd, Sci Operat, Loughborough, Leics, England
[2] Crown Biosci UK Ltd, Vitro Operat, Loughborough, Leics, England
[3] KWS Biotest, Analyt Serv, Bristol, Avon, England
[4] KWS Biotest, Bristol, Avon, England
[5] Crown Biosci UK Ltd, Loughborough, Leics, England
关键词
D O I
10.1016/S0959-8049(16)32930-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
337
引用
收藏
页码:S111 / S111
页数:1
相关论文
共 23 条
  • [21] Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a meta-analysis based on mixed-effect models
    Zheng, Jianqing
    Deng, Yujie
    Huang, Bifen
    Chen, Xiaohui
    FRONTIERS IN MEDICINE, 2023, 10
  • [22] Treatment patterns and clinical outcomes of patients with metastatic non-small cell lung cancer receiving immune checkpoint inhibitors in combination with chemotherapy in the first-line setting in community-based practices in the United States
    Merinopoulou, Evie
    Nordstrom, Beth
    Huse, Samuel
    Trunova, Nataliya
    Kolajo, Christianah
    Chou, Engels
    Klein, Alyssa B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 45 - 45
  • [23] Efficacy of 2nd line treatment with chemotherapy (CT) or immune checkpoint inhibitors (ICIs) for patients (pts) with a prolonged objective response (>6 months) after 1st line therapy for recurrent or metastatic head & neck squamous cell carcinoma (R/M-HNSCC)
    Vienne, A.
    Collet, L.
    Chevalier, T.
    Borel, C.
    Tardy, M. P.
    Huguet, F.
    Richard, S.
    Salas, S.
    Saada-Bouzid, E.
    Fayette, J.
    Daste, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S666 - S666